ERCP在胆胰系统疾病的诊治应用现状及研究进展  

Current Status and Research Progress of ERCP in the Diagnosis and Treatment of Biliary and Pancreatic System Diseases

作　　者：李跃华 龚建平[1] 

机构地区：[1]重庆医科大学附属第二医院肝胆外科,重庆

出　　处：《临床医学进展》2021年第7期3123-3130,共8页Advances in Clinical Medicine

摘　　要：内镜逆行胆胰管造影术(ERCP)自20世纪60年代应用于临床,经过近半个世纪的发展,已经成为目前临床诊治胆胰系统疾病的重要手段。近年来随着内镜仪器的不断更新、内镜医生技术的进步以及对胆胰系统疾病认识的进展,使得ERCP在胆胰疾病诊治中的应用越来越广泛,诊疗程序越来越规范。同时随着无创影像学技术的进步,ERCP的诊断作用略有下降,但其介入治疗的作用更加突显,减少了对于传统创伤治疗的依赖。本文就ERCP技术在胆胰系统疾病中的诊治应用现状及近年来的研究进展作一综述,并对未来的应用前景进行展望。Endoscopic retrograde cholangiopancreatography (ERCP) has been used clinically since the 1960s, after nearly half a century of development, it has become an important method for clinical diagnosis and treatment of biliary and pancreatic system diseases. In recent years, with the continuous updating of endoscopy equipment, the advancement of endoscopists’ technology, and the progress in understanding of biliary and pancreatic diseases, the application of ERCP in the diagnosis and treatment of biliary and pancreatic diseases has become more extensive, and the diagnosis and treatment procedures have become more standardized. At the same time, the diagnostic role of ERCP has declined slightly with the advancement of noninvasive imaging technology. But its intervention role in treatment is more prominent, reducing dependence on traditional trauma therapy. This article summarizes the application status of ERCP technology in biliary and pancreatic system diseases and the research progress in recent years, and look forward to the future application prospects.

关 键 词：内镜逆行胆胰管造影术 胆胰系统疾病 诊断 治疗 

分 类 号：R65[医药卫生—外科学]